We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

0 hedge funds and large institutions have $0 invested in Translate Bio, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 145 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,500% more call options, than puts

Call options by funds: $104K | Put options by funds: $4K

100% less funds holding

Funds holding: 1450 (-145)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $1.85B → $0 (-$1.85B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 145

Holders
Holders Change
-145
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
145
Calls
$104K
Puts
$4K
Net Calls
+$100K
Net Calls Change
+$179K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
-$735K -26,692 Closed
Victory Capital Management
77
Victory Capital Management
Texas
-$733K -26,632 Closed
Principal Financial Group
78
Principal Financial Group
Iowa
-$728K -26,430 Closed
DI
79
DFPG Investments
Utah
-$728K -24,700 Closed
TC
80
TownSquare Capital
Utah
-$706K -24,700 Closed
GAA
81
Green Alpha Advisors
Colorado
-$677K -24,575 Closed
IA
82
IndexIQ Advisors
New York
-$676K -24,534 Closed
MIM
83
MetLife Investment Management
New Jersey
-$667K -24,204 Closed
E
84
Ergoteles
New York
-$661K -24,000 Closed
Legal & General Group
85
Legal & General Group
United Kingdom
-$639K -23,213 Closed
Renaissance Technologies
86
Renaissance Technologies
New York
-$614K -22,300 Closed
EMG
87
ETF Managers Group
New Jersey
-$569K -22,190 Closed
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
-$573K -20,791 Closed
GRP
89
Global Retirement Partners
California
-$560K -20,325 Closed
EAM
90
Erste Asset Management
Austria
-$513K -20,000 Closed
Mitsubishi UFJ Asset Management
91
Mitsubishi UFJ Asset Management
Japan
-$489K -17,746 Closed
GAM
92
Gotham Asset Management
New York
-$454K -16,467 Closed
WSTAM
93
Wilbanks Smith & Thomas Asset Management
Virginia
-$423K -15,348 Closed
Group One Trading
94
Group One Trading
Illinois
-$422K -15,321 Closed
BNP Paribas Asset Management
95
BNP Paribas Asset Management
France
-$413K -15,000 Closed
Prudential Financial
96
Prudential Financial
New Jersey
-$383K -13,920 Closed
SI
97
Shaker Investments
Ohio
-$365K -13,271 Closed
ASRS
98
Arizona State Retirement System
Arizona
-$334K -12,122 Closed
UBS Group
99
UBS Group
Switzerland
-$314K -11,386 Closed
Robeco Institutional Asset Management
100
Robeco Institutional Asset Management
Netherlands
-$312K -11,338 Closed

TBIO Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q3 2021, worth a combined $0 — down 100% from $1.85B a quarter earlier.

Sellers outnumbered buyers: 145 funds closed out of TBIO and 0 opened new positions — a net loss of 145 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Baupost Group, exiting entirely with an estimated $494M sold.

  • 0 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q3 2021, down from 145 in Q2 2021.
  • Funds reported $0 of Translate Bio, Inc. Common Stock stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Translate Bio, Inc. Common Stock positions in Q3 2021 and 145 closed out, a net change of -145 holders.
  • The largest Translate Bio, Inc. Common Stock seller in Q3 2021 was Baupost Group, an estimated $494M sold.

Based on aggregated 13F filings for Q3 2021.